Orally Disintegrating Tablet and Film Technologies - 6th Edition
Publication Date: September 2010
TCI's 6th Edition report on Orally-Disintegrating Tablet and Film Technologies provides a
comprehensive overview of orally disintegrating delivery technologies (tablet and thin film
systems). Also included in this report are market analyses (current and forecasted), details
on pipeline products, life cycle management drug candidates, and business opportunities. The
report specifically identifies orally disintegrating tablet (ODT) and oral thin film (OTF)
products currently available for co-development, co-marketing, and/or licensing. In total,
more than 120 companies are profiled in this report and represent a multitude of partnership
opportunities for companies active in the following segments:
- 45 Orally Disintegrating Tablet Technologies
- 45 Oral Thin Film Technologies
- 17 Excipient Technologies for ODT/OTF
- 26 Tastemasking Technologies applicable to fast-dissolving dosage forms
New to the Sixth Edition:
- Details on formulation and manufacturing techniques for both ODT and OTF products
- Information on oral thin film packaging and converting
- Overview of US ODT Suitability Petitions and Authorized Generic products
- Generic ODT competition in Japan
- Information on the first prescription thin films in the US, EU, and Japan
- Profiles on 20+ additional ODT and oral thin film technologies not covered in the fifth edition
- US FDA Guidance for ODTs
- Appendix outlining all ODTs that have been commercialized (branded and generic)
